Oaktree Acquisition Iii Life Sciences (OACCU) Annual Balance Sheets

Annual · GAAP · USD millions
Access OACCU quarterly Balance Sheets →
The balance sheet data below highlights changes in Oaktree Acquisition Iii Life Sciences's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent1.44
Cash & Short-term Investments1.00
Derivatives, Collateral, Regulatory, Deferred6.72
Prepaid Expense, Current AS0.11
Total Current Assets1.55
Total Assets203.11
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.50
Notes Payable, Current NO0.01
Total Current Liabilities1.30
Total Long-term Debt0.00
Total Liabilities8.32
Stockholders' Equity
Retained Earnings / Accumulated Deficit-6.77
Common Stockholder's Equity-208.33
Non-controlling interests & other201.56
Total Stockholder's Equity-6.77
Liabilities & Stockholder's Equity203.11
4 historic quarters locked

Sign in to unlock the full Oaktree Acquisition Iii Life Sciences balance sheet history.

About Oaktree Acquisition Corp Iii Life Sciences Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 26, 2026
  • Source: d82009d10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-126536

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License